MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Bruker breaks annual sales record in spite of lower Q4 profits | Earnings roundup

Bruker breaks annual sales record in spite of lower Q4 profits | Earnings roundup

By

MassDevice.com Earnings Roundup

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.

Here’s a quick rundown of a few releases over the past couple days:

Bruker breaks annual sales record in spite of lower Q4 profits
Bruker Corp. (NSDQ:BRKR) reported profits of $29.3 million, or 18 cents per diluted share, on sales of $416.1 million during the three months ended Dec. 31. That compares with profits of $43.5 million, or 26 cents per diluted share, on sales of $366.4 million during the same period last year.

Full-year profits were $95.4 million, or 58 cents per diluted share, on sales of $1.30 billion. That compares with profits of $81.2 million, or 49 cents per diluted share, on sales of $1.11 million in 2009.
Read more

Fresenius profits rise 10 percent after sales bump
Fresenius Medical Care AG & Co. (NSDQ:FMS) reported profits of $271.3 million, or 90 cents per diluted share, on sales of $3.17 billion during the three months ended Dec. 31, 2010. That compares with profits of $246.6 million, or 82 cents per diluted share, on sales of $3.04 billion during the same period in 2009.

Full-year profits were $978.5 million, or $3.25 per diluted share, on sales of $12.05 billion. That compares with profits of $891.1 million, or $2.99 per diluted share, on sales of $11.25 billion in 2009.
Read more

Volcano Q4 losses ease as sales jump 14 percent
Volcano Corp. (NSDQ:VOLC) reported a loss of $1.7 million, or 3 cents per diluted share, on sales of $81.2 million during the three months ended Dec. 31. That compares with a loss of $12.1 million, or 25 cents per diluted share, on sales of $71.0 million during the same period in 2009.

Full-year profits were $5.2 million, or 10 cents per diluted share, on sales of $294.1 million. That compares with losses of $29.0 million, or 60 cents per diluted share, on sales of $227.9 million in 2009.
Read more

Synovis Q1 profits almost triple
Synovis Life Technologies Inc. (NSDQ:SYNO) reported profits of $1.8 million or 16 cents per diluted share, on sales of $19.5 million during the three months ended Jan. 31. That compares with profits of $643,000, or 6 cents per diluted share, on sales of $15.2 million during the same period last year.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Texas power grid struggles in heat one year after record cold stopped semiconductor plants
    A heat wave in Texas took at least six power plants offline Friday with high temperatures forecasted to blaze throughout this week. A record cold snap in February 2021 took NXP Semiconductors and Samsung chip fabrication facilities offline for weeks, contributing to a global semicondcutor shortage that is still throttling medical device production. There’s no… […]
  • How Stryker includes users for product design in the digital age
    Medical device developers and manufacturers like Stryker (NYSE:SYK) are changing how they approach design as digital technology becomes more crucial. Four Stryker executives shared how the Kalamazoo, Michigan–based orthopedic device giant is thinking differently about medical product development and how health care providers and patients will ultimately use them. The DeviceTalks Boston panel of Stryker… […]
  • DermaSensor wins MedTech Innovator Mid-Stage Companies Pitch Event
    DermaSensor Inc. — the creator of a handheld, point-and-click device to quickly assess skin lesions for cancer risk — is the winner of the MedTech Innovator Mid-Stage Companies Pitch Event.  The Miami-based mid-stage company beat out 1,000 applicants, more than 20 of which competed on-site May 10–11, 2022 at DeviceTalks Boston. DermaSensor walked away with… […]
  • Steris rises on Street-beating Q4, sets fiscal 2023 guidance
    Steris (NYSE:STE) shares ticked up today on fourth-quarter financial results that came in just ahead of the consensus forecast. The infection prevention technology company — headquartered in Dublin, Ireland, and run operationally out of Mentor, Ohio — posted profits of $52.3 million, or 52¢ per share, on sales of $1.2 billion for the three months… […]
  • Lucira Health asks FDA for EUA on molecular at-home COVID/flu test
    Lucira Health (Nasdaq: LHDX) today said it has asked the FDA for an emergency use authorization (EUA) for its combination COVID-19 and flu test. Emeryville, California–based Lucira said the at-home test would be available with a prescription to test for SARS-CoV-2, Influenza A and Influenza B. The Nucleic Acid Amplification Test (NAAT) platform has a… […]
  • Device commercialization platform AcuityMD raises $31M Series A to fund R&D engineer hiring
    AcuityMD said today it has raised $31 million in Series A funding for its medical device commercialization platform. “With our new funding, we plan to double down on R&D by growing our engineering team from 15 to over 40 over the next year,” AcuityMD co-founder and CEO Michael Monovoukas said in a blog post. “We’ll… […]
  • Rockley Photonics announces $81.5M private placement
    Rockley Photonics (NYSE:RKLY) announced today that it entered into agreements for an $81.5 million private placement. Participating investors agreed to purchase $81.5 million in convertible senior secured notes (due 2026) and warrants to purchase 26.5 million Rockley ordinary shares at an exercise price of $5 per share, subject to certain anti-dilution adjustments. Warrants purchased in… […]
  • Stryker leaders talk medtech trends at DeviceTalks Boston: ‘If you’re slow, you’re going to lose’
    The first day of DeviceTalks Boston closed with a panel of Stryker (NYSE:SYK) executives discussing new tools, technologies and strategies in medtech. Digital VP Tracy Robertson, Digital, Robotics, and Enabling Technologies President Robert Cohen and Surgical Technologies VP of Digital Innovation Siddarth Satish offered their thoughts on industry trends in healthcare and at the Kalamazoo,… […]
  • Medtronic’s VC leader discusses risk, returns, strategy and an ‘ugly truth’
    A panel of medtech investors convened today for DeviceTalks Boston included David Neustaedter, VP of venture capital at Medtronic (NYSE: MDT). He’s spent 14 years in the role, including as director of venture capital at Covidien before Medtronic acquired the company. (Read more in his DeviceTalks speaker bio.) Medtronic has more than $500 million in… […]
  • Here’s where Harvard’s engineering dean sees medtech research going
    Surgical robotics, artificial intelligence, and combatting climate change are but some of the priorities that have Harvard’s engineering school dean excited. Speaking today at DeviceTalks Boston, Frank J. Doyle III described the Harvard John A. Paulson School of Engineering and Applied Sciences as a “well-kept secret” historically. But Harvard engineering is staking out a strong position when it… […]
  • gBETA Medtech accelerator picks its next startups
    The gBETA Medtech virtual accelerator today named the five startups that will participate in the spring program leading up to the June 21 showcase day. The five startups for the spring 2022 cohort are: Mother of Fact: This mobile app for moms with babies offers nutrition tracking, preventative monitoring and daily coaching from licensed dietitians… […]

Leave a Reply